What 25 Analyst Ratings Have To Say About Sarepta Therapeutics
Portfolio Pulse from Benzinga Insights
In the last quarter, 25 analysts have rated Sarepta Therapeutics (NASDAQ:SRPT) with an average price target of $174.6, compared to its current price of $115.9999. The average price target has increased by 6.19% over the past month.
June 23, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sarepta Therapeutics (NASDAQ:SRPT) has an average price target of $174.6 from 25 analysts, indicating potential upside from its current price of $115.9999.
The average price target of $174.6 from 25 analysts suggests a potential upside for Sarepta Therapeutics. The increase in the average price target by 6.19% over the past month indicates growing optimism among analysts.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100